Excerpt: Allegations that your association may have encouraged compounding pharmacists to attempt to impede FDA from evaluating the efficacy and safety of their products, if true, raise serious concerns about your actions. To read the letter, click here.
Letter to Committee on Appropriations Subcommittee on Financial Services and General Government Regarding Online PrivacyDecember 5, 2012 | Letter
To read the letter, click here.
Excerpt: Providing the public with timely access to information about the rulemaking petitions and notices of intent to sue received by the Office of the Administrator and/or Office of General Counsel would significantly increase the transparency of EPA’s regulatory process.” To read the letter, click here.
Letter to HHS Regarding Interagency Working Group to Support Safe and Responsible Development of Unconventional Domestic Natural Gas ResourcesNovember 30, 2012 | Letter
Excerpt: The United States is experiencing an energy renaissance thanks to recent shale gas discoveries and the development of new energy production technologies. This natural gas boom has dramatically enhanced our nation’s energy portfolio, with the potential to transform our economy and create millions of jobs, all the while delivering affordable energy to American families.
Excerpt: In order to effectively and responsibly address the question of clarifying or enhancing FDA’s authority over compounding pharmacies, the committee must identify what happened at the New England Compounding Center (NECC), and why FDA did not use its authority to take enforcement action against NECC until October 2012, after the meningitis outbreak.
Letter to EPA on Proposed Revisions to the National Ambient Air Quality Standards for Particulate MatterNovember 16, 2012 | Letter
Excerpt: We write regarding the Environmental Protection Agency’s proposed revisions to the National Ambient Air Quality Standards for Particulate Matter, published on June 29, 2012, at 77 Fed. Reg. 38890. In particular, we seek further information regarding the estimated compliance costs and public health benefits for the proposed new standards. To read the letter, click here.